GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sunzen Biotech Bhd (XKLS:0148) » Definitions » Change In Receivables

Sunzen Biotech Bhd (XKLS:0148) Change In Receivables : RM2.37 Mil (TTM As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Sunzen Biotech Bhd Change In Receivables?

Sunzen Biotech Bhd's change in receivables for the quarter that ended in Sep. 2023 was RM2.20 Mil. It means Sunzen Biotech Bhd's Accounts Receivable declined by RM2.20 Mil from Jun. 2023 to Sep. 2023 .

Sunzen Biotech Bhd's change in receivables for the fiscal year that ended in Dec. 2022 was RM-41.37 Mil. It means Sunzen Biotech Bhd's Accounts Receivable increased by RM41.37 Mil from Dec. 2021 to Dec. 2022 .

Sunzen Biotech Bhd's Accounts Receivable for the quarter that ended in Sep. 2023 was RM13.62 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sunzen Biotech Bhd's Days Sales Outstanding for the three months ended in Sep. 2023 was 47.83.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sunzen Biotech Bhd's liquidation value for the three months ended in Sep. 2023 was RM21.30 Mil.


Sunzen Biotech Bhd Change In Receivables Historical Data

The historical data trend for Sunzen Biotech Bhd's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunzen Biotech Bhd Change In Receivables Chart

Sunzen Biotech Bhd Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.73 2.56 10.90 -18.96 -41.37

Sunzen Biotech Bhd Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.73 -7.14 7.32 -0.01 2.20

Sunzen Biotech Bhd Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM2.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunzen Biotech Bhd  (XKLS:0148) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sunzen Biotech Bhd's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=13.62/25.982*91
=47.83

2. In Ben Graham's calculation of liquidation value, Sunzen Biotech Bhd's accounts receivable are only considered to be worth 75% of book value:

Sunzen Biotech Bhd's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=22.061-16.553+0.75 * 13.62+0.5 * 11.153
=21.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunzen Biotech Bhd Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sunzen Biotech Bhd's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunzen Biotech Bhd (XKLS:0148) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning, Shah Alam, SGR, MYS, 40460
Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

Sunzen Biotech Bhd (XKLS:0148) Headlines

No Headlines